Search Results - "Livideanu, C. Bulai"

Refine Results
  1. 1

    Long‐term continuation with secukinumab in psoriasis: association with patient profile and initial psoriasis clearance by Ferrières, L., Konstantinou, M. P., Bulai Livideanu, C., Hegazy, S., Tauber, M., Amelot, F., Paul, C.

    Published in Clinical and experimental dermatology (01-10-2019)
    “…Summary Background There are limited data regarding the long‐term continuation with biological therapy for patients with psoriasis. In particular, the reasons…”
    Get full text
    Journal Article
  2. 2

    Higher prevalence of vertebral fractures in systemic mastocytosis, but not in cutaneous mastocytosis and idiopathic mast cell activation syndrome by Degboé, Y., Eischen, M., Apoil, PA, Mailhol, C., Dubreuil, P., Hermine, O., Paul, C., Bulai Livideanu, C., Laroche, M.

    Published in Osteoporosis international (01-06-2019)
    “…Summary Little is known about osteoporosis in mast cell disorders (MCDs) not related to systemic mastocytosis. We described osteoporosis and fractures in MCDs…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Cutaneous mastocytosis in adults with a serum tryptase level < 20 ng mL–1: why we should investigate further by Jendoubi, F., Shourick, J., Negretto, M., Laurent, C., Apoil, P.A., Evrard, S., Mansat‐De Mas, V., Severino‐Freire, M., Mailhol, C., Degboé, Y., Dubreuil, P., Hermine, O., Paul, C., Bulai Livideanu, C.

    Published in British journal of dermatology (1951) (01-08-2021)
    “…Dear Editor, Mastocytosis is a rare disease characterized by the accumulation/proliferation of abnormal mast cells (MCs).1 Mastocytosis is categorized into…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Real-life management of psoriasis with biological agents during pregnancy by Tran, C., Mahé, E., Beylot-Barry, M., Jullien, D., Richard, M.-A., Fougerousse, A.-C., Bouznad, A., Bulai Livideanu, C., Brun, A., Amelot, F., Maccari, F., Aubin, F., Benhadou, F., Paul, C.

    “…French guidelines recommend stopping biologic treatment of psoriasis between 3 and 24 weeks before conception in accordance with the relevant Summary of…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Frequency of isolated cutaneous involvement in adult mastocytosis: a cohort study by Fradet, M., Negretto, M., Tournier, E., Laurent, C., Apoil, P.A., Evrard, S., Degboe, Y., Del Mas, V., Lamant, L., Dubreuil, P., Laroche, M., Mailhol, C., Hermine, O., Paul, C., Bulai Livideanu, C.

    “…Background Mastocytosis is characterized by the accumulation/proliferation of abnormal mast cells. The frequency of isolated cutaneous involvement in adults…”
    Get full text
    Journal Article
  14. 14

    Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis by Bulai Livideanu, C., Apoil, P. A., Lepage, B., Eischen, M., Laurent, C., Laharrague, P., Lamant, L., Tournier, E., Tavitian, S., Pouplard, C., Recher, C., Laroche, M., Mailhol, C., Dubreuil, P., Hermine, O., Blancher, A., Paul, C.

    Published in Clinical and experimental allergy (01-01-2016)
    “…Summary Background Mastocytosis is difficult to diagnose, especially when systemic mast cell activation symptoms are not present or involve only one…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20